These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16643206)

  • 41. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients.
    Lichterfeld M; Schmeisser N; Qurishi N; Vogel M; Brackmann HH; Spengler U; Rockstroh JK
    J Infect; 2005 Apr; 50(3):221-8. PubMed ID: 15780416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
    Yamamoto Y; Yasuoka A; Tachikawa N; Teruya K; Genka I; Yamaguchi M; Yasuoka C; Kikuchi Y; Aoki M; Oka S
    Jpn J Infect Dis; 1999 Dec; 52(6):248-9. PubMed ID: 10738365
    [No Abstract]   [Full Text] [Related]  

  • 43. Liver enzymes elevation after HAART in HIV-HCV co-infection.
    Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
    J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
    Puoti M; Nasta P; Gatti F; Matti A; Prestini K; Biasi L; Carosi G
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):30-42. PubMed ID: 19211929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.
    Snijdewind IJ; Smit C; Godfried MH; Nellen JF; de Wolf F; Boer K; van der Ende ME
    J Infect; 2012 Apr; 64(4):409-16. PubMed ID: 22227465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatotoxicity of antiretroviral drugs.
    Abrescia N; D'Abbraccio M; Figoni M; Busto A; Maddaloni A; De Marco M
    Curr Pharm Des; 2005; 11(28):3697-710. PubMed ID: 16305505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir.
    Palacios R; Vergara S; Rivero A; Aguilar I; Macías J; Camacho A; Lozano F; García-Lázaro M; Pineda JA; Torre-Cisneros J; Márquez M; Santos J
    HIV Clin Trials; 2006; 7(6):319-23. PubMed ID: 17197379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus.
    Cooper CL; Parbhakar MA; Angel JB
    Clin Infect Dis; 2002 May; 34(9):1259-63. PubMed ID: 11941553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV and hepatitis C virus co-infection.
    Sulkowski M
    Hopkins HIV Rep; 1998 Nov; 10(6):8, 12. PubMed ID: 11366132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy.
    Chihrin S; Antoniou T; Raboud J; Shen S; Govan V; Fletcher D; Rachlis A; Kovacs C; Crouzat F; Tilley D; Chang B; Saskin R; Loutfy MR
    AIDS Patient Care STDS; 2007 Jul; 21(7):469-78. PubMed ID: 17651028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.
    Pol S; Lebray P; Vallet-Pichard A
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S65-72. PubMed ID: 14986277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steatohepatitis due to antiretroviral therapy.
    Gayle F; Lee MG; Hanchard B; Mills M
    West Indian Med J; 2008 Jan; 57(1):66-9. PubMed ID: 19565942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatotoxicity in patients prescribed efavirenz or nevirapine.
    Brück S; Witte S; Brust J; Schuster D; Mosthaf F; Procaccianti M; Rump JA; Klinker H; Petzold D; Hartmann M
    Eur J Med Res; 2008 Jul; 13(7):343-8. PubMed ID: 18700192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HIV disease, antiretroviral treatment and the liver--emerging problems].
    Manfredi R
    Recenti Prog Med; 2003 Apr; 94(4):149-53. PubMed ID: 12677783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver enzyme elevation in hepatitis C virus (HCV)-HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes.
    Maida I; Babudieri S; Selva C; D'Offizi G; Fenu L; Solinas G; Narciso P; Mura MS; Núñez M
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):139-43. PubMed ID: 16478395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
    Van Welzen B; Mudrikova T; Arends J; Hoepelman A
    HIV Med; 2012 Aug; 13(7):448-52. PubMed ID: 22413955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
    Francisci D; Giannini S; Baldelli F; Leone M; Belfiori B; Guglielmini G; Malincarne L; Gresele P
    AIDS; 2009 Mar; 23(5):589-96. PubMed ID: 19177019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.